Naloxonazine, a specific mu-opioid receptor antagonist, attenuates the increment of locomotor activity induced by acute methamphetamine in mice

Toxicology Letters
Chih-Cheng ChienLu-Tai Tien

Abstract

Our previous studies indicated that the endogenous opioid system, particularly the mu-opioid receptor, may be involved in the modulation of methamphetamine (METH)-induced increases in locomotor behavior in mice. This study investigates the effects of naloxonazine, a specific mu-opioid receptor antagonist, on the locomotor behavioral response and phosphorylation pattern of dopamine and cAMP-regulated phosphoprotein of Mr32 (DARPP-32) in striatal dopaminergic transmissions induced by acute administration of METH to mice. Mice were injected with a single dose of naloxonazine (20 mg/kg, i.p.) 60 min before injecting (i.p.) either saline or 1 mg/kg of METH. After a 2-h behavioral test, striatal tissues were collected to determine the protein levels of DARPP-32 and the phosphorylated form of DARPP-32 at the Thr34 and Thr75 sites. Results show that pretreatment with naloxonazine significantly attenuated the acute METH-induced increase in locomotor activity and phosphor-Thr75 DARPP-32 levels. Our data indicate that the mu-opioid receptor blockade reduces the acute METH-induced increase in locomotor activity. This effect may be related to the inhibition of DARPP-32 phosphorylation at the Thr75 site in the striatum of the mice.

References

Nov 24, 1999·Biological Psychiatry·E J NestlerG K Aghajanian
Oct 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·A NishiP Greengard
Nov 3, 2001·Science·P Greengard
Nov 13, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Pei-Chun Chen, Jin-Chung Chen
Dec 16, 2004·Journal of Pharmacological Sciences·Tomohisa MoriToshiko Sawaguchi
Aug 27, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Venetia ZachariouEric J Nestler
Feb 17, 2007·Pharmacology, Biochemistry, and Behavior·Paul S FrankelGlen R Hanson
Aug 10, 2007·Neuropharmacology·Anders BorgkvistGilberto Fisone
Sep 27, 2008·Journal of Pharmacological Sciences·Argo VonkAgo Rinken
Feb 20, 2010·PLoS Computational Biology·Takashi NakanoKenji Doya
May 13, 2011·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Tien-Hsiung KuLu-Tai Tien
Sep 3, 2011·Current Neuropharmacology·Lu-Tai Tien, Ing-Kang Ho

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.